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DISCUSSION
Dr Jon S. Matsumura (Chicago, Ill). I enjoyed the study. I
think it’s very important, because you’ve shown a reduction in
mortality with the endovascular compared with open repair in a
pretty large dataset.
In studies that I am familiar with, more than two thirds of the
early deaths after endovascular repair occur after the patient goes
home, so they are no longer inpatients. Because the deaths happen
within 30 days, they are counted as surgical.
Can you adjust the mortality rate in your endovascular group
to account for the shorter length of stay? Can you compare it with
a similar time period for the open? Do you have a 30-day mortality
rate for the endo and open groups?
Dr Patrice L. Anderson. We are unable to estimate a 30-day
mortality rate; we can only estimate in-hospital mortality. Our
access to the New York State dataset (SPARCS) did not include
patient identifiers; consequently we were unable to follow re-
hospitalizations or evidence of deaths out of the hospital. It is
important to reemphasize that we have only analyzed in-hospital
mortality rates for this presentation.
Dr Satish C. Muluk (Pittsburgh, Pa). I have two questions
for you. Do you think the differences between endovascular and
open mortality results could be related to the difference in the type
of aneurysms being done among the open patients in this time
period? And second, the increase in numbers that you saw over the
time period, could that have any connection with patients being
sent in from out of state to the big centers in New York that would
be doing endovascular repair during this period?
Dr. Anderson. I fully agree with your first statement. It may
be that the patients who are getting open repair have technically
difficult anatomy and that they were not candidates for endovas-
cular repair because of the complexity of their case. The type of
aneurysm and the technical difficulty are clinical details that are not
available in large administrative datasets such as SPARCS.
I also agree with the second statement. Patients may have
migrated into New York State to the centers capable of doing
endovascular repair. What we found is that centers performing
endovascular repairs did approximately 60% of the open cases in
2000, but by 2002 they were doing about 78% of the open
repairs. This may indicate that there is some concentration of
open repairs in the institutions that are capable of endovascular
intervention.
Dr Richard M. Green (Rochester, NY). That was nicely
presented, and I appreciate your sending me the manuscript.
I think these results are of critical importance, because they
show that with the introduction of the new technology, and no
basis of past experience, community-based surgeons can already
get better results than with conventional therapy. And I think
you’re to be congratulated for bringing this to our attention.
Many of us have criticized the 1-day, 2-day training programs,
but clearly they work. Can you tell us more about the learning
curve though? I’d be very interested to know, on day 1 are the
results as good as at year 5 of experience?
Dr Anderson. From our current data I am unable to conduct
a longitudinal analysis of how many cases an institution has done in
total, but that would be very interesting for us to look at in the
future.
I can say that the smaller volume centers, performing one to
five cases per year in 2002, have a comparable mortality rate to the
teaching institutions and the centers doing a large number of cases.
The relationship of volume to outcome is always a very inter-
esting and intriguing concept. A challenge with this dataset is that
we do not have patient identifiers, which would be needed to
adequately adjust for preexisting medical conditions. Conse-
quently, we do not have the basis to say that the mortality at the
community level is the same, better, or worse than the rate in a
teaching institution, because there may be sicker patients going to
the teaching institutions, or vice versa. Though we did look at the
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mortality rates between low-volume and high-volume centers, and
found them to be comparable, we’re limited in how much we can
accurately say about the volume outcomes.
Dr Alan Dardik (New Haven, Conn). I enjoyed your talk
greatly. I have three, I hope simple, questions.
First, were you able to verify the accuracy of the endovascular
code; ie, were all the hospitals across the entire state of New York
instantaneously, in October 2000, coding accurately their endo-
vascular repairs as endovascular, or were some of them coded as
open repairs?
Second, the New York database has instructed us on the
importance of both surgeon and hospital volume. Although you
said that you couldn’t tell us any information about surgeon
volume, how about hospital volume in this state?
And last, do you have any information for us about the
hospital charges? How did the cost of endovascular repair compare
with open repair during this time?
Dr Anderson. Starting at the very beginning, certainly in
2000 fewer hospitals were clear on how to code for endovascular
repair. Endovascular repair was approved in 1999 by the FDA;
however, the 3971 ICD-9 code was not provided until October of
2000. In our 2000 data we identified only 131 cases coded as
elective AAA repair under ICD-9 code 39.71. We suspect that
there were more endovascular cases that year and that most of these
ended up in the 39.52 category, which is a kind of a catch-all
category. Some may have also ended up in the open 38.44 cate-
gory. Though we did include some of the 2000 data in the
manuscript, we were very reluctant to make any kind of compari-
sons between the two repairs, because the coded data were limited
for endovascular repair, and the open data may have included
endovascular cases.
Coding accuracy improved in 2001 undoubtedly, and was
fairly well established in 2002. Regarding the relationship between
hospital case volume and outcome, we would need to analyze
risk-adjusted outcomes. This would require access to patient iden-
tifiers, which we do not have. In the institutions that performed the
top 10% of the endovascular repairs, the mortality rate was slightly
higher, though not significantly greater, than the crude mortality
that we presented for the state. Thus we have no indication of a
volume-outcome relationship.
Last, the economic comparisons between these two repairs
will be very interesting for future research. One way to look at
this would be to see how patients are coded under the DRG
system. There is a large difference in hospital reimbursement,
depending on whether patients are coded with or without
comorbidities and complications. What we are seeing with our
data is that endovascular patients have a significant number of
comorbidities. Thus, if patients are properly coded under DRG
110 (with comorbidities and complications), as opposed to 111
(without comorbidities and complications), there is approxi-
mately a $10,000 increase in hospital reimbursement. Therefore
accurate coding has the potential to make endovascular repair
more cost-effective.
Dr John J. Ricotta (Stony Brook, NY). Two questions. This
database allows you to track where the patient came from. Do you
have any data on migration of patients from one zip code or one
area to another area to get this new treatment, particularly the endo
treatment?
And then the second question is, do you have any data on the
specialty of the providers providing endovascular repair, whether
they were all surgeons or whether there were nonsurgical specialists
doing it?
Dr Anderson. The answer to the first question is no. When I
looked at the dataset, I looked at simply what counties were
performing the repair. I did not run what counties the patients
were coming from. It would be interesting to look at the migra-
tion.
As far as who is performing the endovascular interventions, we
do not have any access to physician identifiers, so I cannot tell you
whether they were performed by interventionalists or surgeons.
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